Cleveland Diagnostics
PrivateLast Round
Growth Equity
Jan 17, 2024
Est. Valuation
$13.2M
Total Funding Raised
$77M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Cleveland Diagnostics operates in Healthcare & Life Sciences and is based in Cleveland, Ohio. Its latest recorded funding round was a Growth Equity round in January 2024.
Cleveland Diagnostics is a biotechnology company that develops non-invasive diagnostic tests for early cancer detection using a proprietary platform that analyzes protein structural changes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cleveland Diagnostics Comparables
Compare Cleveland Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OPKO Health | 83% | |
| LynxDx | 81% | |
| Minomic International | 80% |
For institutional investors. Book with your work email.
Cleveland Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | Jan 17, 2024 | ||||
| Convertible Debt | Feb 9, 2021 | ||||
| Convertible Debt | Nov 28, 2017 | ||||
| VC Round | Nov 21, 2016 | ||||
| VC Round | Mar 20, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Cleveland Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Serial Stage Venture Partners | Growth Equity |
| Genomic Health | Convertible Debt |
| Cleveland Clinic Ventures | Convertible Debt, Growth Equity |
| LYFE Capital | Convertible Debt |
| Symbiotic Capital | Growth Equity |
| Novo Holdings | Growth Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2026
Working with Roche for IsoPSA IVD product implementation.
- Jun 20, 2026
Commercial stage product IsoPSA for prostate cancer announced.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- hiresAug 25, 2026
Cleveland Diagnostics, Inc. appoints Valerie Dixon as Chief Financial Officer as it expands commercialization of its IsoPSA prostate cancer test and develops additional IsoClear diagnostic platform applications on Aug 25th '26.
For institutional investors. Book with your work email.
Cleveland Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cleveland Diagnostics's valuation, stock price, and market status.
Is Cleveland Diagnostics a public or private company?
Cleveland Diagnostics is a private company.
What is the current stock price of Cleveland Diagnostics?
Cleveland Diagnostics is a private company, so its shares have no public market price. Caplight tracks Cleveland Diagnostics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cleveland Diagnostics worth (valuation)?
Cleveland Diagnostics's valuation is estimated at $13.2M based on funding round data.
Can I buy Cleveland Diagnostics stock?
Cleveland Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cleveland Diagnostics's last funding round?
Cleveland Diagnostics's most recent funding round was Growth Equity on January 17, 2024.
Who are the main investors in Cleveland Diagnostics?
Key investors in Cleveland Diagnostics include LYFE Capital, Novo Holdings.
Will Cleveland Diagnostics IPO soon?
No public IPO plans have been announced for Cleveland Diagnostics.
How can I track Cleveland Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades in Cleveland Diagnostics's shares on secondary markets.